New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm

被引:169
作者
Renzulli, Matteo [1 ]
Biselli, Maurizio [2 ]
Brocchi, Stefano [1 ]
Granito, Alessandro [3 ]
Vasuri, Francesco [4 ]
Tovoli, Francesco [3 ]
Sessagesimi, Elisa [1 ]
Piscaglia, Fabio [3 ]
D'Errico, Antonietta [4 ]
Bolondi, Luigi [3 ]
Golfieri, Rita [1 ]
机构
[1] Univ Bologna, St Orsola Hosp, Radiol Unit, Dept Diagnost Med & Prevent, Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, St Orsola Hosp, I-40126 Bologna, Italy
[3] Univ Bologna, Dept Med & Surg Sci DIMEC, Unit Internal Med, Bologna, Italy
[4] Univ Bologna, St Orsola Hosp, FAddarii Inst Oncol & Transplantat Pathol, Bologna, Italy
关键词
CONTRAST-ENHANCED MRI; GADOXETIC ACID; HEPATIC NODULES; LIVER-TRANSPLANTATION; HEPATOBILIARY AGENTS; ARTERIAL ENHANCEMENT; IMAGING DIAGNOSIS; BENIGN NODULES; CRITERIA; CM;
D O I
10.1136/gutjnl-2017-315384
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Many improvements have been made in diagnosing hepatocellular carcinoma (HCC), but the radiological hallmarks of HCC have remained the same for many years. We prospectively evaluated the imaging criteria of HCC, early HCC and high-grade dysplastic nodules (HGDNs) in patients under surveillance for chronic liver disease, using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) MRI and diffusion-weighted imaging. Design Our study population included 420 nodules > 1 cm in 228 patients. The MRI findings of each nodule were collected in all sequences/phases. The diagnosis of HCC was made according to the American Association for the Study of Liver Diseases (AASLD) criteria; all atypical nodules were diagnosed using histology. Results A classification and regression tree was developed using three MRI findings which were independently significant correlated variables for early HCC/HCC, and the best sequence of their application in a new diagnostic algorithm (hepatobiliary hypointensity, arterial hyperintensity and diffusion restriction) was suggested. This algorithm demonstrated, both in the entire study population and for nodules <= 2 cm, higher sensitivity (96% [95% CI 93.5% to 97.6%] and 96.6% [95% CI 93.9% to 98.5%], P<0.001, respectively) and slightly lower specificity (91.8% [95% CI 88.6% to 94.1%], P=0.063, and 92.7% [95% CI 88.9% to 95.4%], P=0.125, respectively) than those of the AASLD criteria. Our new diagnostic algorithm also showed a very high sensitivity (94.7%; 95% CI 92% to 96.6%) and specificity (99.3%; 95% CI 97.7% to 99.8%) in classifying HGDN. Conclusion Our new diagnostic algorithm demonstrated significantly higher sensitivity and comparable specificity than those of the AASLD imaging criteria for HCC in patients with cirrhosis evaluated using Gd-EOB-DTPA MRI, even for lesions <= 2 cm. Moreover, this diagnostic algorithm allowed evaluating other lesions which could arise in a cirrhotic liver, such as early HCC and HGDN.
引用
收藏
页码:1674 / 1682
页数:9
相关论文
共 49 条
[1]  
American College of Radiology, CT MRI LI RADSV2017C
[2]   Added value of subtraction imaging in detecting arterial enhancement in small (&lt;3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma [J].
An, Chansik ;
Park, Mi-Suk ;
Kim, Dowhan ;
Kim, Yeo-Eun ;
Chung, Woo-Suk ;
Rhee, Hyungjin ;
Kim, Myeong-Jin ;
Kim, Ki Whang .
EUROPEAN RADIOLOGY, 2013, 23 (04) :924-930
[3]   The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma [J].
Ayuso, Carmen ;
Bruix, Jordi .
HEPATOLOGY INTERNATIONAL, 2014, 8 (01) :4-6
[4]   Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers [J].
Bartolozzi, Carlo ;
Battaglia, Valentina ;
Bargellini, Irene ;
Bozzi, Elena ;
Campani, Daniela ;
Pollina, Luca Emanuele ;
Filipponi, Franco .
ABDOMINAL IMAGING, 2013, 38 (02) :290-296
[5]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[6]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[7]   CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma. Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features [J].
Choi, Jin-Young ;
Lee, Jeong-Min ;
Sirlin, Claude B. .
RADIOLOGY, 2014, 273 (01) :30-50
[8]   Diagnostic criteria for hepatocellular carcinoma ≤3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging [J].
Choi, Sang Hyun ;
Byun, Jae Ho ;
Lim, Young-Suk ;
Yu, Eunsil ;
Lee, So Jung ;
Kim, So Yeon ;
Won, Hyung Jin ;
Shin, Yong Moon ;
Kim, Pyo Nyun .
JOURNAL OF HEPATOLOGY, 2016, 64 (05) :1099-1107
[9]   Hepatocellular carcinoma in liver transplantation candidates: Detection with gadobenate dimeglumine-enhanced MRI [J].
Choi, Seung Hong ;
Lee, Jeong Min ;
Yu, Nam C. ;
Suh, Kyung-Suk ;
Jang, Ja-June ;
Kim, Se Hyung ;
Choi, Byung Ihn .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (02) :529-536
[10]   "Pseudo Washout" Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor [J].
Doo, Kyung Won ;
Lee, Chang Hee ;
Choi, Jae Woong ;
Lee, Jongmee ;
Kim, Kyeong Ah ;
Park, Cheol Min .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (06) :W490-W496